Evidence map›Paper›PMID 36146458›Full record

ReviewVaccines2022

The Roles of Skin Langerhans Cells in Immune Tolerance and Cancer Immunity.

Li Zhou, Aimin Jiang, Jesse Veenstra, David M Ozog, Qing-Sheng Mi

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis.JID innovations : skin science from molecules to population health · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Protective Barriers Provided by the Epidermis.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Li ZhouCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA.ORCID 0000-0002-7028-3865
Aimin JiangCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA.ORCID 0000-0001-9161-5729
Jesse VeenstraCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA.ORCID 0000-0002-3576-855X
David M OzogCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA.
Qing-Sheng MiCenter for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA.ORCID 0000-0002-1411-6827
Henry Ford Health System · US

Funding

Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and FunctionR01AR069681 · NIAMS · HENRY FORD HEALTH SYSTEM · PI MI, QING-SHENG · 2016 to 2020
$1.7M
MicroRNAs regulate skin Langerhans cellsR01AR072046 · NIAMS · HENRY FORD HEALTH SYSTEM · PI ZHOU, LI · 2018 to 2022
$1.6M
Uncover the new subsets of epidermal Langerhans cellsR61AR076803 · NIAMS · HENRY FORD HEALTH SYSTEM · PI ADRIANTO, INDRA, MI, QING-SHENG · 2019 to 2020
$746k
Genetic risk of hidradenitis suppurativa in African AmericansR21AR079089 · NIAMS · HENRY FORD HEALTH SYSTEM · PI ADRIANTO, INDRA, MI, QING-SHENG · 2022 to 2023
$520k
Uncover the new subsets of epidermal Langerhans cellsR33AR076803 · NIAMS · HENRY FORD HEALTH SYSTEM · PI ADRIANTO, INDRA, MI, QING-SHENG · 2021 to 2021
$380k
Decoding TGF-beta signaling pathways in skin langerhans cellsR56AI165991 · NIAID · HENRY FORD HEALTH SYSTEM · PI MI, QING-SHENG, ZHOU, LI · 2022 to 2022
$376k
NIAID NIH HHS R56 AI165991NIAMS NIH HHS R01 AR069681NIAMS NIH HHS R01 AR072046NIAMS NIH HHS R21 AR079089NIAMS NIH HHS R33 AR076803NIAMS NIH HHS R61 AR076803
6 · The paper itself

Abstract

Langerhans cells (LC) are a unique population of tissue-resident macrophages with dendritic cell (DC) functionality that form a network of cells across the epidermis of the skin. Their location at the skin barrier suggests an important role for LC as immune sentinels at the skin surface. The classification of LC as DC over the past few decades has driven the scientific community to extensively study how LC function as DC-like cells that prime T cell immunity. However, LC are a unique type of tissue-resident macrophages, and recent evidence also supports an immunoregulatory role of LC at steady state and during specific inflammatory conditions, highlighting the impact of cutaneous environment in shaping LC functionality. In this mini review, we discuss the recent literature on the immune tolerance function of LC in homeostasis and disease conditions, including malignant transformation and progression; as well as LC functional plasticity for adaption to microenvironmental cues and the potential connection between LC population heterogeneity and functional diversity. Future investigation into the molecular mechanisms that LC use to integrate different microenvironment cues and adapt immunological responses for controlling LC functional plasticity is needed for future breakthroughs in tumor immunology, vaccine development, and treatments for inflammatory skin diseases.

Indexed as

cancer immunitydendritic cells (DC)immune toleranceLangerhans cells (LC)nonmelanoma skin cancerstissue-resident macrophages (TRM)

Identifiers

PMID36146458
PMCPMC9503294
OpenAlexW4293224633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.